Almac Asks: Are you Equipped with an Inspection Ready IRT?

In the race to improve speed and efficiency in drug development, clinical research studies have grown dramatically in the last decade in both numbers and complexity.

Adaptive design, multiple cohorts, randomisation, and detailed dosing instructions have been driving factors in this increase as sponsors are looking to achieve more endpoints within a single protocol. As companies continue to collect higher volumes of data in an effort to shorten the duration and number of trials required for submission, it becomes increasingly difficult for researchers to manage this information. This means the toolsets used to conduct studies are being relied upon more heavily.

Related Intelligence and Suppliers

Commercial Services
Through its Pharma Services Business Unit Almac provides commercial manufacturing and packaging of solid dosage forms in addition to commercial support services and 3PL (third party logistics) which incorporates the management of ordering, financial and distribution. In addition, it offers significant expertise managing the supply and distribution of product into the EU marketplace on behalf of US based companies.
Products